Zdrowie i gospodarka · 04/03/2021
FDA Withdraws BELVIQ Tablets and XR Tablets from Sale
The Food and Drug Administration has withdrawn BELVIQ tablets and XR tablets from sale due to safety or effectiveness concerns, and will not accept new applications for these medications.